Top Markets
#1 GALA GALA +32.47%
#2 Fabric Protocol Fabric Protocol +32.28%
#3 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +31.50%
#4 Bitcoin Cash Bitcoin Cash +31.11%
#5 Tutorial Tutorial +30.85%
#6 Zora Zora +24.99%
#7 Arowana Arowana +22.89%
#8 aPriori aPriori +22.63%
#9 Talus Network Talus Network +22.63%
#10 Useless Coin Useless Coin +22.42%
Coin of the day
GALA GALA
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Achilles Therapeutics plc Achilles Therapeutics plc

Achilles Therapeutics plc

ACHL
Classement en actions #24579
Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused... Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused on immuno-oncology. The firm specializes in creating innovative precision T-cell therapies designed to combat a range of solid tumors. Its primary therapeutic candidates, both currently undergoing Phase I/IIa clinical trials, are CHIRON, aimed at advanced non-small cell lung cancer, and THETIS, targeting metastatic or recurrent melanoma. Beyond these, Achilles is also advancing its pipeline with treatments for head and neck squamous cell carcinoma, renal cell carcinoma, triple-negative breast cancer, and bladder cancer. Initially incorporated as Achilles TX Limited, the company officially adopted the name Achilles Therapeutics Plc in February 2021. Established in 2016, its corporate headquarters are situated in London, United Kingdom.
Prix de l'action
$1.48
Dernière synchronisation: 2025-03-24
Capitalisation boursière
$59.05M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
GB
Échange Achilles Therapeutics plc (ACHL)

Catégorie

Healthcare
Ratio P/B pour Achilles Therapeutics plc (ACHL)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Achilles Therapeutics plc, le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Achilles Therapeutics plc de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH